Nitidine chloride inhibits renal cancer cell metastasis via suppressing AKT signaling pathway
- 1 October 2013
- journal article
- Published by Elsevier BV in Food and Chemical Toxicology
- Vol. 60, 246-251
- https://doi.org/10.1016/j.fct.2013.07.062
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Simvastatin Inhibits Renal Cancer Cell Growth and Metastasis via AKT/mTOR, ERK and JAK2/STAT3 PathwayPLOS ONE, 2013
- Relaxin induces matrix-metalloproteinases-9 and -13 via RXFP1: Induction of MMP-9 involves the PI3K, ERK, Akt and PKC-ζ pathwaysMolecular and Cellular Endocrinology, 2012
- Inhibition of STAT3 Signaling Pathway by Nitidine Chloride Suppressed the Angiogenesis and Growth of Human Gastric CancerMolecular Cancer Therapeutics, 2012
- Roles of matrix metalloproteinases in cancer progression and their pharmacological targetingThe FEBS Journal, 2010
- Interferon alfa-2a versus combination therapy with interferon alfa-2a, interleukin-2, and fluorouracil in patients with untreated metastatic renal cell carcinoma (MRC RE04/EORTC GU 30012): an open-label randomised trialThe Lancet, 2010
- A New Mutational aktivation in the PI3K PathwayCancer Cell, 2007
- A systematic review of the relation between interleukin-2 schedule and outcome in patients with metastatic renal cell cancerEuropean Journal of Cancer, 2004
- PI3K/Akt signalling pathway and cancerCancer Treatment Reviews, 2004
- Oncogenic kinase signallingNature, 2001
- Comparison of In Vitro Activities of Camptothecin and Nitidine Derivatives against Fungal and Cancer CellsAntimicrobial Agents and Chemotherapy, 1999